Fang Quan - Publications

Efficacy, safety, and pharmacokinetics of pumecitinib nasal spray for moderate-to-severe seasonal allergic rhinitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.

Journal: The Lancet regional health. Western Pacific

Published: July 02, 2026

Artemisia annua Sublingual Immunotherapy Is Efficacious and Well Tolerated in Patients With Season Allergic Rhinitis: A Prospective, Open-Label, Multicenter Phase IV Trial.

Journal: Allergy

Published: January 13, 2026

Chinese Position Paper on Biologic Therapy for Allergic Rhinitis.

Journal: Allergy

Published: December 13, 2025

Corticosteroids sparing effect of artemisia annua sublingual immunotherapy: A prospective study in pediatric seasonal allergic rhinoconjunctivitis (INCs sparing and efficacy of Artemisia annua SLIT in pediatric SARC).

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: November 12, 2025

Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis.

Journal: The World Allergy Organization journal

Published: September 10, 2025

Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps.

Journal: Allergy

Published: December 20, 2024

Efficacy and safety of GR1802 in uncontrolled chronic rhinosinusitis with nasal polyps: Placebo-controlled phase 2 trial.

Journal: The Journal of allergy and clinical immunology

Published: September 21, 2024

Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial.

Journal: Nature medicine

Published: August 30, 2024

Clinical efficacy in one-year treatment with Artemisia annua-SLIT drops in monosensitized and polysensitized individuals.

Journal: American journal of otolaryngology

Published: June 15, 2023

Efficacy and safety of Artemisia annua sublingual immunotherapy in patients with seasonal allergic rhinoconjunctivitis over two pollen seasons.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: April 21, 2023

Clinical Efficacy and Safety of Artesimia annua-Sublingual Immunotherapy in Seasonal Allergic Rhinitis Patients Based on Different Intervention Time.

Journal: International archives of allergy and immunology

Published: January 20, 2022

Long non-coding RNA SNHG16, binding with miR-106b-5p, promoted cell apoptosis and inflammation in allergic rhinitis by up-regulating leukemia inhibitory factor to activate the JAK1/STAT3 signaling pathway.

Journal: Human & experimental toxicology

Published: August 19, 2021